Tylenol Has Herculean Effort As Pain Relief Supplier For U.S. Olympians
This article was originally published in The Pink Sheet Daily
Executive Summary
Promotions for Tylenol change course to include niche groups, while also focusing on analgesic safety. The shift coincides with McNeil's decision to switch ad agencies to Deutsch from Saatchi & Saatchi.
You may also be interested in...
NDAC Approach To OTC Switches Highlighted At Corticosteroid Meeting
Panel review provides examples of different attitudes toward switches between OTC experts, other category-specific prescribers.
Plan B Decision Expected In Coming Weeks, Barr CEO Says
Downey says Rx sales of approximately $20 mil. have restricted availability of the emergency contraceptive at pharmacies across the country.
Topical Corticosteroid Adrenal Suppression Risk Precludes OTC Use, Advisory Committe Says
Topical corticosteroid HPA axis suppression risk under "maximal use conditions" should preclude the OTC marketing of the dermatologic products, FDA advisory committees say. Test for hypothalamus, pituitary, adrenal axis suppression is only 70% accurate, committee members note.